Corrigendum to: Lack of Association Between Transforming Growth Factor Beta 1-509C/T and +915G/C Polymorphisms and Chronic Hepatitis B in Iranian Patients [Published in Hepatitis Monthly. 2014 April; 14 (4): e13100]

Mohebbi, Seyed Reza
August 2014
Hepatitis Monthly;Aug2014, Vol. 14 Issue 8, p1
Academic Journal
Correction Notice
A correction to the article "Lack of Association Between Transforming Growth Factor Beta 1-509C/T and +915G/C Polymorphisms and Chronic Hepatitis B in Iranian Patients" that was published in the April 2014 is presented.


Related Articles

  • Chronic hepatitis B and liver schistosomiasis: a deleterious association. Andrade, J. R; Silva, Luciana Diniz; Guimarães, Camila Mendes; Bassetti-Soares, Eric; Cambraia, Rodrigo Dias; Couto, O. F. M.; Teixeira, Rosângela // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jul2014, Vol. 108 Issue 7, p452 

    A correction to the article "Chronic Hepatitis B and Liver Schistosomiasis: A Deleterious Association" that was published in the previous issue is presented.

  • Hepatitis B virus and HIV coinfections can be interpreted in different ways. Alavian, Seyed-Moayed // Journal of Infection & Chemotherapy (Springer Science & Business;Feb2013, Vol. 19 Issue 1, p183 

    A letter to the editor is presented in response to the article "Chronic Hepatitis B in Patients Coinfected With Human Immunodeficiency Virus in Japan: A Retrospective Multicenter Analysis" by S. Yanagimoto in the 2012 issue.

  • First report of superficial venous thrombophiebitis: case report.  // Reactions Weekly;11/24/2012, Issue 1429, p33 

    An abstract of a case study "Superficial venous thromboplebitis associated with pegylated interferon alpha-2a treatment in a patient with chronic hepatitis B," by M. Kalafateli and colleagues is presented.

  • Innovative Indian American Youngsters Among 2019 ExploraVision Winners.  // India -- West;5/17/2019, Vol. 44 Issue 27, pA10 

    No abstract available.

  • Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV? Yapali, Suna; Lok, Anna S. // Gut;Dec2014, Vol. 63 Issue 12, p1833 

    The author focuses on a research related to randomized controlled trial of nucleos(t)ide analogue (NUC) treatment in patients with chronic hepatitis B (CHB) with hepatocellular carcinoma (HCC). Topics discussed include disease progression, significant decrease in fibrosis and HCC carcinogenesis...

  • Entecavir.  // Reactions Weekly;Nov2015, Vol. 1578 Issue 1, p133 

    The article presents a case study of a 37-year-old man who experienced virological breakthrough due to development of entecavir resistance during therapy with entecavir for chronic hepatitis B (CHB).

  • Improving the identification of priority populations to increase hepatitis B testing rates, 2012. van Gemert, Caroline; Julie Wang; Simmons, Jody; Cowie, Benjamin; Boyle, Douglas; Stoove, Mark; Enright, Chris; Hellard, Margaret; Wang, Julie // BMC Public Health;2/1/2016, Vol. 16 Issue 1, p1 

    Background: It is estimated that over 40 % of the 218,000 people with chronic hepatitis B (CHB) in Australia in 2011 are undiagnosed. A disproportionate number of those with undiagnosed infection were born in the Asia-Pacific region. Undiagnosed CHB can lead to ongoing transmission...

  • HBV viremia linked to progression of dysplastic nodules to HCC.  // Hem/Onc Today;10/25/2013, Vol. 14 Issue 20, p20 

    The article presents the results of a study as of October 2013, which showed that dysplastic nodules due to chronic hepatitis B infection have higher possibility of progressing to hepatocellular carcinoma if patients had higher hepatitis B viral loads.

  • Plasma Myeloperoxidase Activity, Apolipoprotein A-1 Expression, and Chronic Hepatitis B. Joob, Beuy; Wiwanitkit, Viroj; Mohamadkhani, Ashraf; Rastgar Jazii, Ferdous // Archives of Iranian Medicine (AIM);Jul2012, Vol. 15 Issue 7, p459 

    A letter to the editor is presented in response to the article "Plasma Myeloperoxidase activity, Apolipoprotein A-1 Expression, and Chronic Hepatitis B," A. Mohamadkhani and colleagues in the July 14, 2011 issue; a reply to the letter is also presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics